Inventor · disambiguated record
Yongke Zhang
Also filed as: ZHANG YONGKE
15 granted patents·8 pending applications·152 citations·filing 2005–2023
93Inventor score
Top patents by PatentIndex Score
23 records- 0198US9266956B2Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodiesAPEXIGEN INC·Filed 2015·Granted Feb 23, 2016·22 cites·28 claims
- 0296US8957193B2Polynucleotides encoding anti-CD40 antibodiesAPEXIGEN INC·Filed 2014·Granted Feb 17, 2015·21 cites·10 claims
- 0395US9556278B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2016·Granted Jan 31, 2017·9 cites·10 claims
- 0495US8778345B2Anti-CD40 antibodiesZHANG YONGKE·Filed 2012·Granted Jul 15, 2014·40 cites·15 claims
- 0595US7399469B2Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancerPDL BIOPHARMA INC·Filed 2005·Granted Jul 15, 2008·22 cites·10 claims
- 0689US9994640B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2017·Granted Jun 12, 2018·6 cites·9 claims
- 0789US9676861B2Anti-CD40 antibodies and methods of useAPEXIGEN INC·Filed 2013·Granted Jun 13, 2017·9 cites·10 claims
- 0887US11001637B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2016·Granted May 11, 2021·2 cites·11 claims
- 0986US9045543B2Humanized anti-CD20 monoclonal antibodyLIU JIE·Filed 2011·Granted Jun 2, 2015·9 cites·6 claims
- 1085US2024158523A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2023·Application pending·0 cites
- 1176US2022049005A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2021·Application pending·0 cites
- 1275US8753634B2Anti-IL-6 receptor antibodies and methods of useLEE SUM WAI PIERRE·Filed 2012·Granted Jun 17, 2014·5 cites·19 claims
- 1372US2022049006A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2021·Application pending·0 cites
- 1471US10259878B2Anti-RANKL antibodies and methods of useAPEXIGEN INC·Filed 2014·Granted Apr 16, 2019·1 cites·21 claims
- 1569US9085621B2Anti-IL-1β antibodiesKE YAOHUANG·Filed 2011·Granted Jul 21, 2015·2 cites·13 claims
- 1668US8986692B2Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibodyLi pierre·Filed 2010·Granted Mar 24, 2015·4 cites·13 claims
- 1760US2018273630A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2018·Application pending·0 cites
- 1858US2008260740A1Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of CancerPDL BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 1953US2019309080A1Anti-rankl antibodies and methods of useAPEXIGEN INC·Filed 2019·Application pending·0 cites
- 2052US9951136B2Anti-IL-6 receptor antibodies and methods of useAPEXIGEN INC·Filed 2014·Granted Apr 24, 2018·0 cites·17 claims
- 2152US2021079111A1Cd19-cd20 bispecific and dual passway car-t and methods for use thereofABCYTE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2249US2020038443A1Multi-function and multi-targeting car system and methods for use thereofABCYTE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2348US9441042B2Anti-KDR antibodies and methods of useKE YAOHUANG·Filed 2012·Granted Sep 13, 2016·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Yongke Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →